In conclusion, we reported for the first time that serum irisin is increased in both benign and malignant neoplasms compared to healthy controls and, after controlling for potential confounding factors including omentin-1, irisin was associated with breast cancer presence. Here, FNDC5 is linked to breast carcinoma.